Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Cell & Gene Therapy Clinical Trials Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing application of cell & gene therapy in cancer research
5.1.1.2. Rising number of chronic diseases worldwide
5.1.1.3. Increasing investment activities by biopharmaceutical companies for cell-based research
5.1.2. Restraints
5.1.2.1. High cost associated with cell & gene therapy clinical trials
5.1.3. Opportunities
5.1.3.1. Growing regulatory approvals from the government for cell & gene therapies
5.1.3.2. Increasing adoption of advanced technologies for cell & gene therapy clinical trials
5.1.4. Challenges
5.1.4.1. Concerns associated with effective data analysis
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Cell & Gene Therapy Clinical Trials Market, by Phase
6.1. Introduction
6.2. Phase I
6.3. Phase II
6.4. Phase III
6.5. Phase IV

7. Cell & Gene Therapy Clinical Trials Market, by Application
7.1. Introduction
7.2. Cardiology
7.3. CNS
7.4. Dermatology
7.5. Endocrine, Metabolic, & Genetic
7.6. Gastroenterology
7.7. Hematology
7.8. Immunology & Inflammation
7.9. Infectious Diseases
7.10. Musculoskeletal
7.11. Oncology
7.12. Ophthalmology

8. Americas Cell & Gene Therapy Clinical Trials Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Cell & Gene Therapy Clinical Trials Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Cell & Gene Therapy Clinical Trials Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Accell Clinical Research, LLC
12.1.2. Alnylam Pharmaceuticals, Inc.
12.1.3. Amgen Inc.
12.1.4. Atlant Clinical Ltd.
12.1.5. Biogen Inc.
12.1.6. Charles River Laboratories International, Inc.
12.1.7. CORESTEM, Inc.
12.1.8. CTI Clinical Trial and Consulting Services, Inc.
12.1.9. Dendreon Pharmaceuticals LLC
12.1.10. HELIXMITH Co., Ltd.
12.1.11. ICON PLC
12.1.12. IQVIA Inc.
12.1.13. Kolon TissueGene, Inc.
12.1.14. Laboratory Corporation of America Holdings
12.1.15. Medpace Holdings, Inc.
12.1.16. Novartis AG
12.1.17. Novotech Pty Limited
12.1.18. Parexel International Corporation
12.1.19. Ppd, Inc.
12.1.20. ProPharma Group Holdings, LLC
12.1.21. PSI CRO
12.1.22. SGS S.A.
12.1.23. Syneos Health, Inc.
12.1.24. Veristat, LLC
12.1.25. Wuxi AppTec Inc.
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. CELL & GENE THERAPY CLINICAL TRIALS MARKET RESEARCH PROCESS
FIGURE 2. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
FIGURE 3. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL & GENE THERAPY CLINICAL TRIALS MARKET DYNAMICS
FIGURE 7. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
FIGURE 8. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. CELL & GENE THERAPY CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. CELL & GENE THERAPY CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. CELL & GENE THERAPY CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 6. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY CNS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ENDOCRINE, METABOLIC, & GENETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY IMMUNOLOGY & INFLAMMATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY MUSCULOSKELETAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 30. CANADA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 32. MEXICO CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. CHINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 42. CHINA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. INDIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 44. INDIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 45. INDONESIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 46. INDONESIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. JAPAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 48. JAPAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. MALAYSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 50. MALAYSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. PHILIPPINES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 52. PHILIPPINES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. SINGAPORE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 54. SINGAPORE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. SOUTH KOREA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 56. SOUTH KOREA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. TAIWAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 58. TAIWAN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. THAILAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 60. THAILAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. VIETNAM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 62. VIETNAM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. EUROPE, MIDDLE EAST & AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 66. DENMARK CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 67. DENMARK CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. EGYPT CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 69. EGYPT CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. FINLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 71. FINLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. FRANCE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 73. FRANCE CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. GERMANY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 75. GERMANY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. ISRAEL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 77. ISRAEL CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. ITALY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 79. ITALY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. NETHERLANDS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 81. NETHERLANDS CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. NIGERIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 83. NIGERIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. NORWAY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 85. NORWAY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. POLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 87. POLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. QATAR CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 89. QATAR CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. RUSSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 91. RUSSIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. SAUDI ARABIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 93. SAUDI ARABIA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. SOUTH AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 95. SOUTH AFRICA CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. SPAIN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 97. SPAIN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. SWEDEN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 99. SWEDEN CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. SWITZERLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 101. SWITZERLAND CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. TURKEY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 103. TURKEY CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED ARAB EMIRATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 105. UNITED ARAB EMIRATES CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM CELL & GENE THERAPY CLINICAL TRIALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. CELL & GENE THERAPY CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 109. CELL & GENE THERAPY CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 110. CELL & GENE THERAPY CLINICAL TRIALS MARKET LICENSE & PRICING